Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in HLN — Haleon plc

CIK 1423053 MIAMI, FL
Back to HLN Full portfolio

Position in HLN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$15,517,020
+$5,488,352 QoQ
Shares Held
1,663,132
+66.0% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#40
of 640 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in HLN Over Time

Shares Held

Position Value (USD)

Derivatives in HLN

reported options exposure · as of Jun 30, 2026
CallValue
$107,295
CallShares
11,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $1,255,121,114 across 64 Drug Manufacturers - Specialty & Generic names. HLN ranks #12 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 9,668,611 $237,944,516
2 ZTS
Zoetis Inc.
 3,188,263 $229,108,578
3 UTHR
UNITED THERAPEUTICS Corp
 304,692 $165,091,266
4 LNTH
Lantheus Holdings, Inc.
 1,376,480 $152,706,691
5 INDV
Indivior Pharmaceuticals, Inc.
 2,667,827 $109,460,941
6 ALKS
Alkermes plc.
 1,645,101 $86,203,291
7 SUPN
Supernus Pharmaceuticals, Inc.
 1,373,982 $63,903,902
8 HIMS
Hims & Hers Health, Inc.
 846,936 $29,363,271

All Filings in HLN

Export CSV
45 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,517,020 1,663,132
2026-06-30 $107,295 11,500
2026-03-31 $173,173 17,300
2026-03-31 $10,028,668 1,001,865
2025-12-31 $140,529 13,900
2025-12-31 $107,166 10,600
2025-12-31 $75,654,271 7,483,113
2025-09-30 $106,743 11,900
2025-09-30 $230,529 25,700
2025-09-30 $33,367,789 3,719,932
2025-06-30 $321,470 31,000
2025-06-30 $47,399,195 4,570,800
2025-03-31 $47,334 4,600
2025-03-31 $61,532,707 5,979,855
2025-03-31 $580,356 56,400
2024-12-31 $17,172 1,800
2024-12-31 $1,050,354 110,100
2024-12-31 $58,247,356 6,105,593
2024-09-30 $213,716 20,200
2024-09-30 $12,744,413 1,204,576
2024-09-30 $1,058 100
2024-06-30 $40,474 4,900
2024-06-30 $46,678,424 5,651,141
2024-06-30 $50,386 6,100
2024-03-31 $111,694,515 13,156,009
2024-03-31 $50,940 6,000
2024-03-31 $227,532 26,800
2023-12-31 $3,995,212 485,445
2023-12-31 $1,729,123 210,100
2023-12-31 $836,168 101,600
2023-09-30 $3,059,867 367,331
2023-09-30 $1,670,998 200,600
2023-09-30 $896,308 107,600
2023-06-30 $28,039 3,346
2023-06-30 $2,261,762 269,900
2023-06-30 $1,054,204 125,800
2023-03-31 $1,527,878 187,700
2023-03-31 $1,514,854 186,100
2023-03-31 $600,707 73,797
2022-12-31 $5,008,000 626,000
2022-12-31 $7,580,240 947,530
2022-12-31 $2,057,600 257,200
2022-09-30 $983,863 161,554
2022-09-30 $822,150 135,000
2022-09-30 $5,954,193 977,700

Report a Problem

Category
Description
Email (optional, for follow-up)